Despite much effort, synthetic small diameter vascular grafts still face limited success due to vascular wall thickening known as intimal hyperplasia (IH). Compliance mismatch between graft and native vessels has been proposed to be one of a key mechanical factors of synthetic vascular grafts that could contribute to the formation of IH. While many methods have been developed to determine compliance both in vivo and in vitro, the effects of compliance mismatch still remain uncertain. This review aims to explain the biomechanical factors that are responsible for the formation and development of IH and their relationship with compliance mismatch. Furthermore, this review will address the current methods used to measure compliance both in vitro and in vivo. Lastly, current limitations in understanding the connection between the compliance of vascular grafts and the role it plays in the development and progression of IH will be discussed.

Current understanding of intimal hyperplasia and effect of compliance in synthetic small diameter vascular grafts.

Objective: We investigate the field feasibility of carotid stiffness measurement using ARTSENS® Touch and report the first community-level data from India. Method: In an analytical cross-sectional survey among 1074 adults, we measured specific stiffness index ( $\beta $ ), pressure-strain elastic modulus ( $\text{E}_{\text {p}}$ ), arterial compliance (AC), and one-point pulse wave velocity (PWV $_{\beta }$ ) from the left common carotid artery. Data for established risk factors (waist circumference, blood pressure, plasma glucose, triglycerides, and HDL-C) were also collected. The association of carotid stiffness with age, gender, hypertension/diabetes, smoking, and clustering of risk factors was studied. Results: Measurements were repeatable with a relative difference (RD) between consecutive readings of $\sim 80$ % of arterial diameter values. The average RDs for $\beta $ , $\text{E}_{\text {p}}$ , AC, and PWV $_{\beta }$ , were 20.51%, 22.31%, 25.10%, and 14.13%, respectively. Typical range for stiffness indices among females and males were $\beta $ : 8.12 ± 3.59 vs 6.51 ± 2.78, $\text{E}_{\text {p}}$ : 113.24 ± 56.12 kPa vs 92.33 ± 40.65 kPa, PWV $_{\beta }$ : 6.32 ± 1.38 ms−1 vs 5.81 ± 1.16 ms−1, and AC: 0.54 ± 0.36 mm2 kPa−1 vs 0.72 ± 0.38 mm2 kPa−1. Mean $\beta $ , $\text{E}_{\text {p}}$ , and PWV $_{\beta }$ increased (and mean AC decreased) across decades of age; the trend persisted even after excluding hypertensives and subjects with diabetes. The odds ratio of presence of multiple risk factors for $\text{E}_{\text {p}} \ge93.71$ kPa and/or PWV $_{\beta } \ge6.56$ ms−1 was ≥ 2.12 or above in males. In females, it was just above 2.00 for $\text{E}_{\text {p}} \ge91.21$ kPa and/or PWV $_{\beta } \ge5.10$ ms−1 and increased to ≥ 3.33 for $\text{E}_{\text {p}} \ge143.50$ kPa and ≥ 3.25 for PWV $_{\beta } \ge7.31$ ms−1. Conclusion: The study demonstrated the feasibility of carotid stiffness measurement in a community setting. A positive association between the risk factors and carotid artery stiffness provides evidence for the device’s use in resource-constrained settings. Clinical Impact: The device paves the way for epidemiological and clinical studies that are essential for establishing population-level nomograms for wide-spread use of carotid stiffness in clinical practice and field screening of ‘at-risk’ subjects.

/pdf/assessment-of-carotid-arterial-stiffness-in-community-2r3upvw80i.pdf

Assessment of Carotid Arterial Stiffness in Community Settings With ARTSENS

Embodiments herein disclose a method and system for cuff-less blood pressure (BP) measurement of a subject. The method includes measuring, by one or more sensors, a local pulse wave velocity (PWV) and/or blood pulse waveforms of an arterial wall of the subject. Further, the method includes measuring, by an ultrasound transducer, a change in arterial dimensions over a cardiac cycle of the arterial wall of the subject. The arterial dimensions include an arterial distension and an end-diastolic diameter. Furthermore, the method includes measuring, by a controller unit, BP of the subject based on the local PWV and the change in arterial dimensions.

Method and system for cuff-less blood pressure (bp) measurement of a subject

Abstract Purpose Existing technologies to measure central blood pressure (CBP) intrinsically depend on peripheral pressure or calibration models derived from it. Pharmacological or physiological interventions yielding different central and peripheral responses compromise the accuracy of such methods. We present a high-frame-rate ultrasound technology for cuffless and calibration-free evaluation of BP from the carotid artery. The system uses a pair of single-element ultrasound transducers to capture the arterial diameter and local pulse wave velocity (PWV) for the evaluation of beat-by-beat BP employing a novel biomechanical model. Materials and methods System’s functionality assessment was conducted on eight male subjects (26 ± 4 years, normotensive and no history of cardiovascular risks) by perturbing pressure via short-term moderate lower body negative pressure (LBNP) intervention (−40 mmHg for 1 min). The ability of the system to capture dynamic responses of carotid pressure to LBNP was investigated and compared against the responses of peripheral pressure measured using a continuous BP monitor. Results While the carotid pressure manifested trends similar to finger measurements during LBNP, the system also captured the differential carotid-to-peripheral pressure response, which corroborates the literature. The carotid diastolic and mean pressures agreed with the finger pressures (limits-of-agreement within ±7 mmHg) and exhibited acceptable uncertainty (mean absolute errors were 2.4 ± 3.5 and 2.6 ± 4.0 mmHg, respectively). Concurrent to the literature, the carotid systolic and pulse pressures (PPs) were significantly lower than those of the finger pressures by 11.1 ± 9.4 and 11.3 ± 8.2 mmHg, respectively (p < .0001). Conclusions The study demonstrated the method’s potential for providing cuffless and calibration-free pressure measurements while reliably capturing the physiological aspects, such as PP amplification and dynamic pressure responses to intervention.

https://www.tandfonline.com/doi/pdf/10.1080/08037051.2021.2022453?needAccess=true

High-frame-rate A-mode ultrasound for calibration-free cuffless carotid pressure: feasibility study using lower body negative pressure intervention

Coronavirus disease 2019 (COVID-19) is reported to have long-term effects on cardiovascular health and physical functioning, even in the nonhospitalized population. The physiological mechanisms underlying these long-term consequences are however less well described. We compared cardiovascular risk factors, arterial stiffness, and physical functioning in nonhospitalized patients with COVID-19, at a median of 6 mo postinfection, versus age- and sex-matched controls. Cardiovascular risk was assessed using blood pressure and biomarker concentrations (amino-terminal pro-B-type-natriuretic-peptide, high-sensitive cardiac troponin I, C-reactive protein), and arterial stiffness was assessed using carotid-femoral pulse wave velocity. Physical functioning was evaluated using accelerometry, handgrip strength, gait speed and questionnaires on fatigue, perceived general health status, and health-related quality of life (hrQoL). We included 101 former patients with COVID-19 (aged 59 [interquartile range, 55–65] yr, 58% male) and 101 controls. At 175 [126–235] days postinfection, 32% of the COVID-19 group reported residual symptoms, notably fatigue, and 7% required post-COVID-19 care. We found no differences in blood pressure, biomarker concentrations, or arterial stiffness between both groups. Former patients with COVID-19 showed a higher handgrip strength (43 [33–52] vs. 38 [30–48] kg, P = 0.004) and less sleeping time (8.8 [7.7–9.4] vs. 9.8 [8.9–10.3] h/day, P < 0.001) and reported fatigue more often than controls. Accelerometry-based habitual physical activity levels, gait speed, perception of general health status, and hrQoL were not different between groups. In conclusion, one in three nonhospitalized patients with COVID-19 reports residual symptoms at a median of 6 mo postinfection, but we were unable to relate these symptoms to increases in cardiovascular risk factors, arterial stiffness, or physical dysfunction. NEW & NOTEWORTHY We examined cardiovascular and physical functioning outcomes in nonhospitalized patients with COVID-19, at a median of 6 mo postinfection. When compared with matched controls, minor differences in physical functioning were found, but objective measures of cardiovascular risk and arterial stiffness did not differ between groups. However, one in three former patients with COVID-19 reported residual symptoms, notably fatigue. Follow-up studies should investigate the origins of residual symptoms and their long-term consequences in former, nonhospitalized patients with COVID-19.

Long-term cardiovascular health status and physical functioning of nonhospitalized patients with COVID-19 compared with non-COVID-19 controls

OBJECTIVE The conventional medical imaging modalities used for arterial stiffness measurement are non-scalable and unviable for field-level vascular screening. The need for an affordable, easy-to-operate automated non-invasive technologies remains unmet. To address this need, we present a portable image-free ultrasound device-ARTSENS® Pen, that uses a single-element ultrasound transducer for carotid stiffness evaluation. APPROACH The performance of the device was clinically validated on a cohort of 523 subjects. A clinical-grade B-mode ultrasound imaging system (ALOKA eTracking) was used as the reference. Carotid stiffness measurements were taken using the ARTSENS® Pen in sitting posture emulating field scenarios. MAIN RESULTS A statistically significant correlation (r > 0.80, p < 0.0001) with a non-significant bias was observed between the measurements obtained from the two devices. The ARTSENS® Pen device could perform highly repeatable measurements (with variation smaller than 10%) on a relatively larger percentage of the population when compared to the ALOKA system. The study results also revealed the sensitivity of ARTSENS® Pen to detect changes in arterial stiffness with age. SIGNIFICANCE The easy-to-use technology and the automated algorithms of the ARTSENS® Pen make it suitable for cardiovascular risk assessment in resource-constrained settings.

ARTSENS® Pen-portable easy-to-use device for carotid stiffness measurement: technology validation and clinical-utility assessment.

This invention relates to medical monitoring and analysis, and more particularly to automated evaluation of arterial stiffness for non-invasive cardiovascular screening. The system tracks and measures motion of carotid artery in the human body using ultrasound based mechanism. Once position of the carotid artery is detected, a wall motion correlation check mechanism is used to measure motion of the artery wall echoes from one frame to another and to ensure that the artery wall motion only is continuously tracked and measured for cardiovascular screening. Further, using values of certain parameters measured during the ultrasound tracking, arterial compliance is measured. Further, from the arterial compliance parameter, arterial stiffness and other associated heart diseases are identified.

Automated evaluation of arterial stiffness for a non-invasive screening

Over past few years our group has been developing a fully automated and low-cost device, ARTSENS (ARTerial Stiffness Evaluation for Non-invasive Screening), to enable non-experts to measure arterial stiffness (AS). It uses a single element ultrasound transducer to obtain A-mode frames from a superficial artery such as the common carotid artery (CCA) and analyzes them to obtain the stiffness parameters of the vessel. We have earlier demonstrated that ARTSENS can accurately measure local arterial stiffness (LAS) and regional arterial stiffness (RAS) by tracing the distension waveforms of the CCA and the femoral artery. In this paper, we show that it is possible to estimate the augmentation index (AIx), a measure of the global arterial mechanics, from the distension waveforms obtained by ARTSENS. AIx measurements from ARTSENS are compared against the state-of-the-art Hitachi-Aloka eTRACKING system for 107 volunteers. Both devices show excellent agreement with a correlation coefficient (r) = 0.82 (p < 0.0001), which is comparable to similar studies reported in the literature. This development makes ARTSENS a unique device that can measure the three most widely used indices of arterial mechanics—LAS, RAS and the AIx.

https://iopscience.iop.org/article/10.1088/2057-1976/2/1/015007/pdf

Suresh Seshadri

Papers

ARTSENS® Pen-portable easy-to-use device for carotid stiffness measurement: technology validation and clinical-utility assessment.

Automated evaluation of arterial stiffness for a non-invasive screening

Comparison of measurement of the augmentation index from ARTSENS and eTRACKING